When a family history exists, the disease is termed "familial pulmonary arterial hypertension", (FPAH). IPAH and FPAH are now considered to be genetic disorders linked to mutations in the "BMPR2" gene, which encodes a receptor for bone morphogenetic proteins, as well as the "5-HT(2B)" gene, which codes for a serotonin receptor.